参考文献

[ 1 ] 　裴凌鹏, 吴　颖. 多肽研究进展[ J ]. 首都师范大学学报(自然科学版) , 2004, 25 (3) : 56 - 60.

[ 2 ] 　张　晟, 杜　建, 孙　蕊, 等. 多肽类药物控制释放体系的研究[ J ]. 高分子通报, 2005, 2 (1) : 14 - 19.

[ 3 ] 　Gao X, Kim KS, Liu D. Nonviral gene delivery: what we knowand what is next[ J ]. AAPS J , 2007, 9 (1) : E92 - E104.

[ 4 ] 　MartinME, Rice KG. Pep tide2guided gene delivery[ J ]. AAPSJ , 2007, 9 (1) : E18 - E19.

[ 5 ] 　Marshall NB, Oda SK, London CA, et al. Arginine2rich cell2penetrating pep tides facilitate delivery of antisense oligomers intomurine leukocytes and alter p re2mRNA sp licing[ J ]. J Imm unolM ethods, 2007, 325 (1 /2) : 114 - 126.

[ 6 ] 　KichlerA, Mason AJ, Bechinger B. Cationic amphipathic histi2dine2rich pep tides for gene delivery [ J ]. B iochim B iophy Acta,2006, 1758 (3) : 301 - 307.

[ 7 ] 　MorrisMC, Chaloin L, Heitz F, et al. Translocating pep tidesand p roteins and their use for gene delivery[ J ]. Curr Opin B io2tech, 2000, 11 (5) : 461 - 466.

[ 8 ] 　王士斌, 刘源岗, 翁连进. 多肽在前体药物与药物载体方面的应用[ J ]. 国外医学生物医学工程分册, 2002, 25 ( 3 ) :139 - 142.

[ 9 ] 　Muratovska A, EcclesMR. Conjugate for efficient delivery of shortinterfering RNA ( siRNA) into mammalian cells[ J ]. FEBS Lett,2004, 558: 63 - 68.

[ 10 ] 　Moriguchi R, Kogure K, Akita H, et al. A multifunctionalenvelope type nano device for novel gene delivery of siRNA p las2mids[ J ]. Int J Pharm , 2005, 301 (1 /2) : 277 - 285.

[ 11 ] 　Suk JS, Suh J, Choy K, et al. Gene delivery to differentiatedneurotyp ic cells with RGD and H IV Tat pep tide functionalizedpolymeric nanoparticles [ J ]. B iom aterials, 2006, 27 ( 29 ) :5143 - 5150.

[ 12 ] 　Lee SH, Kim SH, Park TG. Intracellular siRNA delivery systemusing polyelectrolyte comp lex micelles p repared from VEGFsiRNA2PEG conjugate and cationic fusogenic pep tide [ J ]. B io2chem B iophys Res Comm un, 2007, 357 (2) : 511 - 516.

[ 13 ] 　ManoM, Teod?sio C, Paiva A, et al. On the mechanisms of theinternalization of S4132PV cell2penetrating pep tide [ J ]. B iochemJ , 2005, 390 ( Pt 2) : 603 - 612.

[ 14 ] 　李　达, 王青青, 余　海. 多肽作为非病毒转基因载体组件的研究进展[ J ]. 国际生物医学工程杂志, 2006, 29 ( 5 ) :307 - 310.

[ 15 ] 　Boeckle S, Wagner E, OgrisM. C2versus N2terminally linkedmelittin polyethylenimine conjugates: the site of linkage stronglyinfluences activity ofDNA polyp lexes[ J ]. J GeneM ed, 2005, 7(10) : 1335 - 1347.

[ 16 ] 　丁　昊, 匡安仁. 受体介导的蛋白多肽靶向药物载体的应用研究[ J ]. 生物医学工程学杂志, 2001, 18 (1) : 129 - 13.

[ 17 ] 　Ge J, Huang YS, Hu X, et al. A surface2modified baculovirusvectorwith imp roved gene delivery to B2lymphocytic cells[ J ]. JB iotechnol, 2007, 129 (3) : 367 - 372.

[ 18 ] 　Kawamura K, Oishi J, Kang JH, et al. Intracellular signal2responsive gene carrier for cell2specific gene exp ression[ J ]. B io2m acrom olecules, 2005, 6 (2) : 908 - 913.

[ 19 ] 　Koppelhus U, Nielsen PE. Cellular delivery of pep tide nucleicacid ( PNA) [ J ]. Adv D rug Deliv Rev, 2006, 55 ( 2 ) : 267 -280.

[ 20 ] 　J? rver P, LangelU. The use of cell2penetrating pep tides as a toolfor gene regulation[ J ]. Drug Discov Today, 2004, 9 (9) : 395 - 402.

[ 21 ] 　艾　国, 杜丽娜, 梅兴国. 蛋白质多肽类药物新剂型与新技术发展动态[ J ]. 中国生化药物杂志, 2004, 25 ( 6) : 366 -369.

[ 22 ] 　Kim JY, Kim TH, Kim SS. Anti2inflammatory effect of a humanp rothrombin fragment222derived pep tide, NSA9, in EOC2 micro2glia[ J ]. B iochem B iophys Res Comm un, 2008, 368 ( 3) : 779 -785.

[ 23 ] 　王志超, 安玉会. 生物活性肽的研究进展[ J ]. 河南医学研究, 2004, 13 (4) : 353 - 356.

[ 24 ] 　Gusarova GA, Wang IC, MajorML. et al. A cell2penetratingARF pep tide inhibitor of FoxM1 in mouse hepatocellular carcino2ma treatment[ J ]. J Clin Invest, 2007, 117 (1) : 99 - 111.

[ 25 ] 　Dasgup ta P, Sun J, Wang S, et al. Disrup tion of the Rb2Raf21interaction inhibits tumor growth and angiogenesis[ J ]. M ol CellB iol, 2004, 24 (21) : 9527 - 9541.

[ 26 ] 　MelisM, Forrer F, Capello A, et al. Up2regulation of somatosta2tin recep tor density on rat CA20948 tumors escaped from low dose[ 177Lu2DOTA0, Tyr3 ] octreotate therapy [ J ]. Q J M ed M olIm ag, 2007, 51 (4) : 324 - 333.